This indicates that HCK may be an important regulator of TEL/ABL-dependent cancer progression because kinase-dead HCK mutants inhibited the progression of TEL/ABL transformed cells and the phosphorylation of ERK1/2 and AKT 48. Here, ETV6 is linked to cancer.